Over the past 12‑18 months the Single‑lumen Central Venous Catheter market has accelerated through strategic collaborations and regulatory momentum. In March 2023, Medtronic partnered with Boston Scientific to co‑develop a antimicrobial‑coated single‑lumen catheter, aiming to reduce catheter‑related bloodstream infections. The same year, Becton, Dickinson & Company completed its acquisition of C. R. Bard’s vascular access unit, consolidating market share and expanding its product portfolio. In July 2023, Teleflex launched the first Bluetooth‑enabled single‑lumen catheter that streams real‑time pressure data to electronic health records, marking a significant technology leap. The U.S. FDA’s updated guidance on antimicrobial stewardship, released in September 2023, has prompted manufacturers to prioritize safety‑focused designs. Meanwhile, Europe’s MDR implementation has increased demand for fully documented, single‑use devices. On the financing side, a €45 million Series B round led by Sofinnova Partners enabled a German start‑up to scale its biodegradable catheter line across North America. These developments signal a shift toward integrated, data‑driven solutions and heightened compliance, shaping Single‑lumen Central Venous Catheter industry trends for the next decade.